Pharmaceutical Stocks List


Related Industries: Asset Management Biotechnology Business Services Chemicals Data Storage Diagnostics & Research Diversified Industrials Drug Manufacturers - General Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Farm & Construction Equipment Health Information Services Household & Personal Products Information Technology Services Internet Content & Information Lumber & Wood Production Medical Devices Medical Distribution Medical Instruments & Supplies Packaging & Containers Pharmaceutical Retailers Pharmaceutical Retailers Pollution & Treatment Controls Security & Protection Services Semiconductor Equipment & Materials Software - Application Specialty Chemicals Specialty Finance Steel Waste Management

Related ETFs - A few ETFs which own one or more of the above listed Pharmaceutical stocks.

Pharmaceutical Stocks Recent News

Date Stock Title
May 8 TEVA Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter
May 8 AVDL Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...
May 8 TEVA Teva Pharmaceutical Industries Limited 2024 Q1 - Results - Earnings Call Presentation
May 8 TEVA UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue risea
May 8 AVDL Avadel Pharmaceuticals GAAP EPS of -$0.30 misses by $0.29, revenue of $27.18M beats by $1.28M
May 8 TEVA Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy
May 8 BCO The Brink's Non-GAAP EPS of $1.52 beats by $0.29, revenue of $1.23B beats by $20M
May 8 TEVA Teva Pharm Q1 profit misses estimates, revenue risea
May 8 TEVA Teva Pharmaceutical reports mixed Q1 results; reaffirms FY24 outlook
May 8 BCO Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance
May 8 AVDL Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 8 TEVA Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
May 8 CBT Cabot Second Quarter 2024 Earnings: EPS: US$1.51 (vs US$1.30 in 2Q 2023)
May 8 TEVA Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
May 8 TEVA Investor Sentiment Falls Further, Dow Gains For Fifth Session
May 8 TEVA Uber, Lyft And 3 Stocks To Watch Heading Into Wednesday
May 8 CBT Cabot Corp (CBT) Q2 2024 Earnings Call Transcript Highlights: Strong Performance and Strategic ...
May 8 CBT Q2 2024 Cabot Corp Earnings Call
May 7 TEVA Teva Earnings Are Soon. What Could Keep the Stock Gains Going.
May 7 TEVA 20 States with the Highest Fertility Rates in the US
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags